There were 2,046 press releases posted in the last 24 hours and 440,762 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Kyverna Therapeutics, Inc. Stockholders Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Class Action Against KYTX  

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image